NCT04138316View on ClinicalTrials.gov

CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study

CompletedOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

January 2, 2020

Primary Completion Date

December 16, 2022

Study Completion Date

December 16, 2022

Conditions
MigraineHead Pain
Interventions
DRUG

Candesartan

Treatment with Candesartan

Trial Locations (1)

47003

Hospital Clínico Universitario Valladolid, Valladolid

All Listed Sponsors
lead

Hospital Clínico Universitario de Valladolid

OTHER

NCT04138316 - CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study | Biotech Hunter | Biotech Hunter